Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Title Journalsort ascending

Ganessan Kichenadasse MBBS, FRACP, John O. Miners PhD, Arduino A. Mangoni MBBS, PhD, FRACP, Christos S. Karapetis MBBS, FRACP, Ashley M. Hopkins PhD and Michael J. Sorich PhD

 May 2021 Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy Journal of the National Comprehensive Cancer Network

Karyn Hede

 August 2017 Project Data Sphere to Make Cancer Clinical Trial Data Publicly Available Journal of the National Cancer Institute

Omar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski

 March 2020 Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials Journal of Cancer Research and Clinical Oncology

Omar Abdel-Rahman

 February 2018 Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study Journal of Cancer Research and Clinical Oncology

Kaiwen Deng, Hongyang Li, and Yuanfang Guan

 February 2020 Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning iScience

Mika Murtojarvia, Anni S. Halkolab, Antti Airolaa, Teemu D. Laajala, Tuomas Mirttid, Tero Aittokalliob, Tapio Pahikkalaa

 January 2020 Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets International Journal of Medical Informatics

Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins 

 May 2020 Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients International Journal of Clinical Oncology

Detian Deng, Yu Du, Zhicheng Ji, Karthik Rao, Zhenke Wu, Yuxin Zhu, R. Yates Coley

 November 2017 Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach F1000 Research

Soren Wengel Mogensen, Anne H. Petersen, Ann-Sophie Buchardt, Niels Richard Hansen

 November 2017 Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients F1000 Research

Motoki Shiga

 November 2017 Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer F1000 Research

Massimiliano Zanin

 November 2017 Using complex networks for refining survival prognosis in prostate cancer patient F1000 Research

Sebastian Pölsterl, Pankaj Gupta, Lichao Wang, Sailesh Conjeti, Amin Katouzian, Nassir Navab

 July 2017 Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research

Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkio, Laura L. Elo

 May 2019 A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer F1000 Research

Anway Giryes, Hani Oweira, Meinrad Mannhart, and Omar Abdel-Rahman

 July 2018 Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials Expert Review of Gastroenterology and Hepatology

Pages